STONEBRIDGE CLINICAL LIMITEDActive
Key figures
Like most small UK companies, STONEBRIDGE CLINICAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 24,803 | 37,338 | 15,901 | 33,429 | 23,602 |
| Total assets | — | — | — | — | — |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | 758 | 8,440 | 54 | 19,306 | 15,605 |
| Average number of employees | 2 | 2 | 2 | 2 | 2 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the Company during the financial year continued to be that of consultancy services to the pharmaceutical industry.
As described in the company's latest filed accounts.
Summary: STONEBRIDGE CLINICAL LIMITED
Company
STONEBRIDGE CLINICAL LIMITED is a private limited company registered with Companies House under company number SC474687. It was incorporated on 8 Apr 2014. Its status is active. The registered office is in Glasgow (G2). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files small company accounts (filleted). Net assets were £15,605, down 19.2% on the previous year. Cash at bank and in hand was £23,602. The company had an average of 2 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 15 Apr 2027.